Haemonetics (HAE) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.12 --0%
EPS Growth %: -0.9%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: -0.9%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.48, $0.02 better than the analyst estimate of $0.46. Revenue for the quarter came in at $233.4 million versus the consensus estimate of $237.37 million.
Haemonetics reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
- Softbank stock target raised at Citi on profit growth
- Air Products cancels Louisiana clean energy project, faces $2.9B charge
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
